Related Experiment Video
Updated: May 9, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
RSK2 and its binding partners: an emerging signaling node in cancers
Hye Suk Lee1,2,3, Sung-Jun Cho4, Han Chang Kang2,3
1BK21-4th, College of Pharmacy, The Catholic University of Korea, 43, Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.
Abstract:
The growth factor-mediated mitogen-activated protein kinase (MAPK) signaling pathways in cancer development have become increasingly important in the discovery of therapeutic agents for the treatment of cancer. RSK2 has been historically overlooked in studies regarding its involvement in physiology and signaling pathways related to human diseases, except for Coffin-Lowry syndrome, because it is located downstream of ERKs. For the last 25 years, the authors' laboratory has made groundbreaking discoveries regarding the role of RSK2, especially by elucidating its binding partners, signaling network, and crosstalk. RSK2 is an important emerging target for developing anticancer drugs. Nevertheless, further studies on the detailed mechanism and signaling network are necessary to avoid the unexpected effects of RSK2 inhibitors. This paper describes a new paradigm of RSK2, where it works as a signaling node to modulate diverse cellular processes, including cell proliferation and transformation, cell cycle regulation, chromatin remodeling, and immune response and inflammation regulation.
Insights
Ribosomal S6 Kinase 2 (RSK2) is a key signaling node in cancer, modulating cell proliferation, transformation, and immune responses. Understanding its complex network is crucial for developing effective anticancer drugs and avoiding side effects.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Mitogen-activated protein kinase (MAPK) pathways are critical in cancer development and therapeutic agent discovery.
- Ribosomal S6 Kinase 2 (RSK2), downstream of ERKs, has been understudied in human diseases except for Coffin-Lowry syndrome.
- RSK2's role in cancer signaling and its potential as a therapeutic target are gaining attention.
Purpose of the Study:
- To elucidate the comprehensive role of RSK2 in cancer development.
- To detail RSK2's binding partners, signaling network, and crosstalk.
- To establish a new paradigm for RSK2 as a central signaling node.
Main Methods:
- Extensive laboratory research over 25 years.
- Elucidation of RSK2 binding partners.
- Analysis of RSK2's signaling network and crosstalk.
Main Results:
- RSK2 acts as a signaling node regulating diverse cellular processes.
- Identified RSK2's modulation of cell proliferation, transformation, and cell cycle.
- Demonstrated RSK2's role in chromatin remodeling, immune response, and inflammation.
Conclusions:
- RSK2 is an emerging and important target for anticancer drug development.
- A deeper understanding of RSK2's mechanism and signaling network is essential to avoid adverse effects of inhibitors.
- RSK2's multifaceted role highlights its significance in cancer biology.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
11:00Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
MAPK Signaling Cascades
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...